Pharmaceutical News

RSS

Inhibiting use of antibiotics may be more effective in reducing C.diff infection

New ways are needed to fight the infection Clostridium difficile and better use of antibiotics could be key, according to the authors of ground-breaking research.

26 Sep 2013

Soligenix awarded $6.4M contract to advance preclinical development of OrbeShield for GI ARS

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense medical countermeasures where there remains an unmet medical need, announced today that it has been awarded a contract valued at up to $6.4 million by the US Department of Health and Human Service's National Institutes of Health (specifically funded by the National Institute of Allergy and Infectious Diseases or NIAID).

25 Sep 2013

Redd Remedies earns Better Nutrition Magazine's Best of Supplements Award for Gouch!

Redd Remedies, a leading provider of natural, condition-specific, health and wellness supplements, is this year's recipient of Better Nutrition Magazine's Best of Supplements Award with its all-natural, gluten-free Gouch!.

25 Sep 2013

Janssen signs license agreement with PATH for early development HIV-1 medicine rilpivirine

Janssen R&D Ireland announced today it has signed a license agreement with PATH for the early development of the human immunodeficiency virus type 1 medicine rilpivirine in a long-acting injection (depot formulation) as potential pre-exposure prophylaxis against HIV infection.

25 Sep 2013

Drug to treat metastatic castration-resistant prostate cancer delays progression of pain and quality of life deterioration in men

Abiraterone acetate, a recently FDA-approved drug used to treat men with metastatic castration-resistant prostate cancer, significantly delays progression of pain and quality of life deterioration when taken in conjunction with prednisone.

25 Sep 2013

Cardiome partners with LifePharma to commercialize BRINAVESS in Cyprus

Cardiome Pharma Corp. today announced that its subsidiary, Cardiome Development AG, has entered into an agreement with LifePharma (Z.A.M) Ltd., to sell and distribute BRINAVESS (vernakalant intravenous) exclusively in Cyprus.

24 Sep 2013

Majority of Michiganders oppose prescription-only approach on popular medicines containing PSE

The Consumer Healthcare Products Association released the following statement today on a recent poll of Michigan voters conducted by The Tarrance Group and underwritten by CHPA.

24 Sep 2013

Quartette tablets now available in U.S. for prevention of pregnancy

Teva Women's Health, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., today announced that the recently approved Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets are now available via prescription in the U.S. for the prevention of pregnancy.

24 Sep 2013

NCI Funds Development Of Chrysalis’ Brain Tissue Damage Treatment

The National Cancer Institute awarded Chrysalis BioTherapeutics a $1.5 million contract to continue development of Chrysalin® to mitigate radiotherapy-induced damage to normal brain tissue. The project is a collaboration between Chrysalis, Baylor College of Medicine, and the University of Texas Medical Branch (UTMB).

24 Sep 2013

Abbvie, Galapagos Ink Up To $405M CF Collaboration

...

24 Sep 2013

Astrazeneca Licenses 3 X-Chem Drug Discovery Programs

...

24 Sep 2013

Messages that warn consumers about potentially harmful side effects increase product sales

Drug ads often warn of serious side effects, from nausea and bleeding to blindness, even death. New research suggests that, rather than scaring consumers away, these warnings can improve consumers' opinions and increase product sales when there is a delay between seeing the ad and deciding to buy or consume the product.

24 Sep 2013

Cisplatin plus radiotherapy and HDRB proves beneficial in stage IIIB cervical cancer

Adding the chemotherapy drug cisplatin to a treatment plan of radiation therapy (RT) and high-dose-rate brachytherapy (HDRB) for stage IIIB cervical cancer is beneficial, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

24 Sep 2013

Frequency of marijuana use not linked to health services utilization or health status

Researchers from Boston Medical Center and Boston University School of Medicine have found frequency of marijuana use was not significantly associated with health services utilization or health status. These findings currently appear online in the Journal of General Internal Medicine.

24 Sep 2013

Researchers find reassuring evidence of H1N1 influenza vaccine's safety during pregnancy

Researchers from Boston University's Slone Epidemiology Center and UC San Diego, in collaboration with the American Academy of Allergy Asthma and Immunology, have found 'reassuring' evidence of the H1N1 influenza vaccine's safety during pregnancy.

24 Sep 2013

Pretravel consultations, malaria preventive medications save money for travelers to West Africa

Not only do U.S. travelers to West Africa who consult health providers before they leave and take prescribed preventive medications substantially reduce their risk of contracting malaria, they also reduce costs to their health insurance providers and, in most cases, to themselves.

24 Sep 2013

Study: Ciclopirox drug completely eradicates infectious HIV from cell cultures

The topical anti-fungal drug Ciclopirox causes HIV-infected cells to commit suicide by jamming up the cells' powerhouse, the mitochondria—according to a study by researchers at Rutgers New Jersey Medical School. And unlike current anti-HIV drugs, Ciclopirox completely eradicates infectious HIV from cell cultures, with no rebound of virus when the drug is stopped.

24 Sep 2013

Researchers find evidence of H1N1 influenza vaccine's safety during pregnancy

Researchers from the University of California, San Diego School of Medicine and Boston University, in collaboration with the American Academy of Allergy Asthma and Immunology (AAAAI), have found evidence of the H1N1 influenza vaccine's safety during pregnancy.

24 Sep 2013

Researchers discover drug that halts growth of brain tumor cells

Working with mice, Johns Hopkins researchers have discovered that weeks of treatment with a repurposed FDA-approved drug halted the growth of - and ultimately left no detectable trace of - brain tumor cells taken from adult human patients.

24 Sep 2013

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

Novartis announced today that the European Commission approved once-daily Ultibro® Breezhaler® (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). In addition, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved once-daily Ultibro® Inhalation Capsules (glycopyrronium 50 mcg / indacaterol 110 mcg), delivered through the Breezhaler® device, for relief of various symptoms due to airway obstruction in chronic obstructive pulmonary disease (COPD). Ultibro® Breezhaler® / Ultibro® Inhalation Capsules were developed under the name QVA149.

23 Sep 2013

Pharmaceutical News

Inhibiting use of antibiotics may be more effective in reducing C.diff infection

Soligenix awarded $6.4M contract to advance preclinical development of OrbeShield for GI ARS

Redd Remedies earns Better Nutrition Magazine's Best of Supplements Award for Gouch!

Janssen signs license agreement with PATH for early development HIV-1 medicine rilpivirine

Drug to treat metastatic castration-resistant prostate cancer delays progression of pain and quality of life deterioration in men

Cardiome partners with LifePharma to commercialize BRINAVESS in Cyprus

Majority of Michiganders oppose prescription-only approach on popular medicines containing PSE

Quartette tablets now available in U.S. for prevention of pregnancy

NCI Funds Development Of Chrysalis’ Brain Tissue Damage Treatment

Abbvie, Galapagos Ink Up To $405M CF Collaboration

Astrazeneca Licenses 3 X-Chem Drug Discovery Programs

Messages that warn consumers about potentially harmful side effects increase product sales

Cisplatin plus radiotherapy and HDRB proves beneficial in stage IIIB cervical cancer

Frequency of marijuana use not linked to health services utilization or health status

Researchers find reassuring evidence of H1N1 influenza vaccine's safety during pregnancy

Pretravel consultations, malaria preventive medications save money for travelers to West Africa

Study: Ciclopirox drug completely eradicates infectious HIV from cell cultures

Researchers find evidence of H1N1 influenza vaccine's safety during pregnancy

Researchers discover drug that halts growth of brain tumor cells

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News